By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panelists generally agreed that the CFO's sale of shares under a 10b5-1 plan was not a significant signal, but they were divided on the company's prospects. The main concerns were slow growth, potential customer concentration, and reliance on payment processing revenue, while the opportunity lies in the company's recurring revenue model and potential margin leverage.
Risk: Slow growth and potential customer concentration or procurement-cycle softness, as well as reliance on payment processing revenue and potential donor fatigue.
Opportunity: Recurring revenue model and potential margin leverage.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
The company's CFO sold 6,205 shares valued at ~$194,00.
The sale represented 9% of Anderson's direct holdings, reducing his direct position from 69,074 to 62,869 shares.
All shares sold and remaining are held directly; no indirect or derivative holdings are reported for this transaction.
This cloud software provider for mission-driven organizations reported a sale by its CFO amid a challenging year for its stock.
Chad Anderson, Executive VP and CFO of Blackbaud (NASDAQ:BLKB), reported the sale of 6,205 shares of common shares in an open-market transaction on June 1, 2026, according to a SEC Form 4 filing.
| Metric | Value | |---|---| | Shares sold (direct) | 6,205 | | Transaction value | $194,279 | | Post-transaction shares (direct) | 62,869 | | Post-transaction value (direct ownership) | $2.1 million |
Transaction value based on SEC Form 4 reported price ($31.31); post-transaction value based on June 1 market close ($32.74).
What proportion of Chad Anderson's direct Blackbaud holdings did this sale represent?
This disposition accounted for 8% of Anderson's direct Common Stock holdings at the time, reducing his position from 69,074 to 62,869 shares.Is there evidence of indirect or derivative participation in this transaction?
No indirect or derivative holdings were reported in this filing; both the shares sold and those retained are held directly by Anderson, with no involvement of trusts, LLCs, or options.
| Metric | Value | |---|---| | Revenue (TTM) | $1.1 billion | | Net income (TTM) | $141.3 million | | Dividend yield | N/A |
Blackbaud is a provider of cloud software solutions tailored to the social gooda sector. The company’s strategy centers on delivering integrated SaaS platforms that enable nonprofit and mission-driven organizations to manage fundraising, engagement, and financial operations efficiently.
The Blackbaud executive conducted his recent sale under a 10b5-1 trading plan. That means these transactions, including the timing, were set under prearranged terms. Designed to prevent insiders from taking advantage of material information ahead of time, by definition, investors can’t glean information from this type of sale.
Turning to the stock’s performance, Blackbaud’s returns have been disappointing, to say the least. Looking at the last year, the shares have lost 55.6%. That’s badly trailed major equity indexes. During this period, the S&P 500 index returned 24.6%, and the tech-heavy Nasdaq Composite had a 32.5% total return.
Blackbaud’s board of directors eliminated the dividend in early 2020. While that was understandable given the uncertainty created by the COVID-19 pandemic, it hasn’t reinstated the payout, as many companies have done.
The company’s first-quarter revenue grew 4.2% year over year. Management expects its full-year top line to increase 4% to 4.5%.
Before you buy stock in Blackbaud, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Blackbaud wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $443,191! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,258,838!
Now, it’s worth noting Stock Advisor’s total average return is 941% — a market-crushing outperformance compared to 206% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 8, 2026. *
Lawrence Rothman, CFA has no position in any of the stocks mentioned. The Motley Fool recommends Blackbaud. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"Insider trading activity here is not a reliable near-term signal; Blackbaud’s upside hinges on accelerating nonprofit SaaS growth and margin expansion, not on the CFO’s share sale."
Chad Anderson, Blackbaud's CFO, sold 6,205 shares for about $194k (roughly 8% of his direct stake) under a 10b5-1 plan, implying diversification rather than a confidence pivot. The stock’s ~55% Y/Y drop and a 4%–4.5% full-year revenue guide pull the narrative toward ongoing headwinds in nonprofit SaaS. Yet the business remains a recurring-revenue model with potential for margin leverage as the cost base normalizes post-COVID. The real risk is nonprofit-budget and procurement cyclicality; the upside hinges on stronger upsell/renewal momentum, not insider activity. Overall, the article’s framing shouldn’t be read as a decisive signal on fundamentals.
Insider sales—even if preplanned—can foreshadow worries about future quarters; a meaningful stake reduction might reflect CFO concerns beyond diversification, especially in a stressed growth story.
"The 10b5-1 sale is irrelevant; the core problem is a lack of revenue acceleration that renders the current valuation unsustainable without a significant strategic pivot."
The CFO's sale is essentially noise, as it was executed under a 10b5-1 plan, neutralizing any signal regarding internal sentiment. The real story here is the fundamental stagnation: a 4% top-line growth rate for a SaaS provider in a high-interest rate environment is anemic. With the stock down over 50% in a year, the market is clearly pricing in a loss of competitive moat. Without a dividend or aggressive buybacks, there is no 'value' floor here, and the growth narrative has stalled. Investors are effectively holding a legacy software asset that is struggling to pivot to high-growth cloud metrics.
If Blackbaud's margins are expanding despite low revenue growth, the stock could be a deep-value play for a private equity takeover, as the niche market dominance in the 'social good' sector provides stable, sticky cash flows.
"A 55% drawdown on 4% revenue growth and 12.8% net margins suggests valuation compression, not fundamental deterioration—but the burden is on management to prove Q1 growth accelerates or margins expand, or this is a value trap."
The article buries its own lede: this sale is legally meaningless because it's under a 10b5-1 plan—pre-arranged, not discretionary. That's the opposite of a red flag. More material: BLKB is down 55.6% YoY while Nasdaq is up 32.5%, yet the company grew revenue 4.2% in Q1 and guides 4–4.5% full-year growth. That's a massive valuation reset, not operational collapse. The real question is whether a mission-driven SaaS provider with $1.1B revenue and $141M net income (12.8% margin) at depressed multiples represents opportunity or a value trap. The article's dismissal—'Blackbaud wasn't one of them'—is marketing, not analysis.
If BLKB's 4% revenue growth is the best management can do in a recovery, the stock may deserve to trade at a discount; nonprofit tech adoption is structural, not cyclical, and slower growth could indicate market saturation or competitive pressure the earnings haven't yet reflected.
"Blackbaud's anemic 4-4.5% revenue outlook and 55.6% trailing underperformance indicate operational stagnation that a pre-scheduled insider sale does nothing to mitigate."
The CFO sale of 6,205 BLKB shares at $31.31 under a 10b5-1 plan is routine and reveals nothing about timing or material information. Yet the stock's 55.6% drop over twelve months, 4-4.5% full-year revenue guidance, and zero dividend since 2020 point to structural weakness in its nonprofit SaaS niche. With TTM revenue of $1.1B and net income of $141M, the business generates cash, but slow organic growth versus peers suggests pricing pressure or customer retention issues the filing does not address. Post-sale direct ownership of 62,869 shares remains material but does not offset the broader performance gap to the S&P 500.
The 10b5-1 plan was established in advance, stripping any informational content from the trade, while positive net income and subscription revenue provide evidence of durable cash flow that could support a rebound if growth stabilizes.
"A modest but non-trivial insider sale in a heavily de-rated stock should not be dismissed as noise, as it can signal management awareness of ongoing growth challenges and risk to renewals."
Insider sales under a 10b5-1 plan aren’t automatically meaningful, but a 6,205-share sale (~8% of his direct stake) into a 55% YoY rout deserves more scrutiny than noise. It hints management hedging exposure in a slow-growth, mission-driven SaaS cycle, not pure diversification. The bigger risk remains demand/renewal momentum and potential customer-concentration or procurement-cycle softness; profitability alone may not re-rate unless growth cadence improves.
"Blackbaud's reliance on payment processing makes it highly sensitive to macroeconomic donor fatigue, which is a greater risk than mere SaaS saturation."
Claude, you hit on the 'value trap' risk, but we are missing the elephant in the room: Blackbaud's heavy reliance on payment processing revenue. If their core SaaS growth is stagnant, their 'take rate' on nonprofit transactions becomes the primary volatility driver. This isn't just about software adoption; it's about the health of charitable giving. If donor fatigue hits, BLKB's revenue isn't just slow—it's structurally impaired. The margin expansion is irrelevant if the volume of processed donations craters.
"Donor fatigue is plausible but unproven; customer concentration risk is material and absent from this discussion."
Gemini's donor-fatigue thesis is speculative—charitable giving data doesn't show structural collapse, and BLKB's payment-processing revenue mix isn't disclosed in the article. More critical: nobody has addressed customer concentration or churn rates, which would validate or demolish the 'sticky cash flow' narrative. If 40%+ revenue comes from top-10 nonprofits, 4% growth masks dangerous retention risk. That's the real test of moat durability.
"Donor fatigue and churn risks compound under stagnant growth, hitting multiple revenue streams at once."
Claude correctly flags the lack of disclosed payment mix, yet that doesn't invalidate Gemini's donor-fatigue link to the 4-4.5% guidance. Softening charitable volumes would simultaneously pressure both subscription renewals and transaction fees, creating correlated downside that top-client concentration metrics alone fail to capture and that could extend the valuation reset beyond a simple moat debate.
The panelists generally agreed that the CFO's sale of shares under a 10b5-1 plan was not a significant signal, but they were divided on the company's prospects. The main concerns were slow growth, potential customer concentration, and reliance on payment processing revenue, while the opportunity lies in the company's recurring revenue model and potential margin leverage.
Recurring revenue model and potential margin leverage.
Slow growth and potential customer concentration or procurement-cycle softness, as well as reliance on payment processing revenue and potential donor fatigue.